AZD8329

DRUG3 trials

Sponsors

AstraZeneca

Conditions

HealthyHealthy MenMaleOverweightType 2 Diabetes Mellitus

Phase 1

A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses

CompletedNCT00935662

AstraZenecaHealthy Men

Start: 2009-07-31End: 2010-08-31Target: 119Updated: 2010-09-13

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329

CompletedNCT01207089

AstraZenecaHealthy, Male, Overweight

Start: 2010-09-30End: 2010-12-31Target: 45Updated: 2011-05-10

A Study Conducted Over 3 Periods to Look at the Drug in the Body

CompletedNCT01225939

AstraZenecaType 2 Diabetes Mellitus

Start: 2010-11-30End: 2010-12-31Target: 18Updated: 2011-03-02